D. Western Therapeutics FY Loss Y632.00M Vs Loss Y1.29B

Dow Jones

Feb 13

    D. Western Therapeutics Institute Inc. (4576.TO) 
    Japan 
    Year Ended December 31 
GROUP              2025                   2024 
Revenue            Y387.00 mln     Y471.00 mln 
Operating Profit   (Y619.00 mln)   (Y1.21 bln) 
Pretax Profit      (Y630.00 mln)   (Y1.23 bln) 
Net Profit         (Y632.00 mln)   (Y1.29 bln) 
Per share 
  Earnings         (Y13.19)           (Y36.74) 
 
    Figures in parentheses are losses. 
 
    Results are based on Japanese accounting standards.

(END) Dow Jones Newswires

    D. Western Therapeutics Institute Inc. also released the following forecasts: 
GROUP                Year Ending 
                        Dec 2026 
Revenue              Y300.00 mln 
Operating Profit   (Y780.00 mln) 
Pretax Profit      (Y800.00 mln) 
Net Profit         (Y800.00 mln) 
Per share 
  Earnings              (Y14.75) 
 
    Figures in parentheses are losses. 
 
    Results are based on Japanese accounting standards.

This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.

(END) Dow Jones Newswires

February 13, 2026 01:39 ET (06:39 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2611618073"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2611618073\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2611618073?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-13 14:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2611618073","market":"fut","top_or_hot":-1,"title":"D. Western Therapeutics FY Loss Y632.00M Vs Loss Y1.29B","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n    D. Western <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Institute Inc. (4576.TO) \n    Japan \n    Year Ended December 31 \nGROUP              2025                   2024 \nRevenue            Y387.00 mln     Y471.00 mln \nOperating Profit   (Y619.00 mln)   (Y1.21 bln) \nPretax Profit      (Y630.00 mln)   (Y1.23 bln) \nNet Profit         (Y632.00 mln)   (Y1.29 bln) \nPer share \n  Earnings         (Y13.19)           (Y36.74) \n \n    Figures in parentheses are losses. \n \n    Results are based on Japanese accounting standards. \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n</font><font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n    D. Western Therapeutics Institute Inc. also released the following forecasts: \nGROUP                Year Ending \n                        Dec 2026 \nRevenue              Y300.00 mln \nOperating Profit   (Y780.00 mln) \nPretax Profit      (Y800.00 mln) \nNet Profit         (Y800.00 mln) \nPer share \n  Earnings              (Y14.75) \n \n    Figures in parentheses are losses. \n \n    Results are based on Japanese accounting standards. \n</pre>\n<p>\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 13, 2026 01:39 ET (06:39 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>D. Western Therapeutics FY Loss Y632.00M Vs Loss Y1.29B</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nD. Western Therapeutics FY Loss Y632.00M Vs Loss Y1.29B\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-02-13 14:39</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n    D. Western <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Institute Inc. (4576.TO) \n    Japan \n    Year Ended December 31 \nGROUP              2025                   2024 \nRevenue            Y387.00 mln     Y471.00 mln \nOperating Profit   (Y619.00 mln)   (Y1.21 bln) \nPretax Profit      (Y630.00 mln)   (Y1.23 bln) \nNet Profit         (Y632.00 mln)   (Y1.29 bln) \nPer share \n  Earnings         (Y13.19)           (Y36.74) \n \n    Figures in parentheses are losses. \n \n    Results are based on Japanese accounting standards. \n</pre>\n<p>\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 13, 2026 01:39 ET (06:39 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2611618073","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2611618073","pubTimestamp":1770964740,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LENZ":"Therapeutics","BK4539":"次新股","BK4168":"多种金属与采矿","WRN":"西方铜金","BK4139":"生物科技","BK4007":"制药"},"translate_title":"D.Western Therapeutics财年亏损Y632.00 M vs亏损Y1.29B","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WRN":1.5,"LENZ":1.5},"content_text":"D. Western Therapeutics Institute Inc. (4576.TO) \n    Japan \n    Year Ended December 31 \nGROUP              2025                   2024 \nRevenue            Y387.00 mln     Y471.00 mln \nOperating Profit   (Y619.00 mln)   (Y1.21 bln) \nPretax Profit      (Y630.00 mln)   (Y1.23 bln) \nNet Profit         (Y632.00 mln)   (Y1.29 bln) \nPer share \n  Earnings         (Y13.19)           (Y36.74) \n \n    Figures in parentheses are losses. \n \n    Results are based on Japanese accounting standards. \n\n\n  (END) Dow Jones Newswires\n\n\n\n    D. Western Therapeutics Institute Inc. also released the following forecasts: \nGROUP                Year Ending \n                        Dec 2026 \nRevenue              Y300.00 mln \nOperating Profit   (Y780.00 mln) \nPretax Profit      (Y800.00 mln) \nNet Profit         (Y800.00 mln) \nPer share \n  Earnings              (Y14.75) \n \n    Figures in parentheses are losses. \n \n    Results are based on Japanese accounting standards. \n\n\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n\n\n  (END) Dow Jones Newswires\n\n\n  February 13, 2026 01:39 ET (06:39 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}